Search

Your search keyword '"Ferrarini, Alessia"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Ferrarini, Alessia" Remove constraint Author: "Ferrarini, Alessia" Database Unpaywall Remove constraint Database: Unpaywall
41 results on '"Ferrarini, Alessia"'

Search Results

1. Broad therapeutic benefit of myosin inhibition in hypertrophic cardiomyopathy

2. Data from Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery

3. Supplementary Tables S1-S3 and Figure S1-S3. from Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery

4. Supplementary Tables S1-S3 and Figure S1-S3. from Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery

5. Early administration of tofacitinib in COVID ‐19 pneumonitis: An open randomised controlled trial

8. Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality

9. Activation of amino acid metabolic program in cardiac HIF1-alpha-deficient mice

10. Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients

11. ALDH4A1 is an atherosclerosis auto-antigen targeted by protective antibodies

12. Abstract 16335: Metabolic Reprogramming From Glycolysis to Amino Acid Utilization in Cardiac Hif1 Alpha Deficient Mice

13. Subclinical progression of systemic sclerosis-related cardiomyopathy

14. ECM deposition is driven by caveolin-1–dependent regulation of exosomal biogenesis and cargo sorting

15. Tocilizumab in Covid-19 Interstitial Pneumonia: A Phase II Pilot Study

16. Decreased serum levels of inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients

17. Activation of amino acid metabolic program in response to impaired glycolysis in cardiac HIF1 deficient mice

19. Sequential Bone-Marrow Cell Delivery of VEGFA/S1P Improves Vascularization and Limits Adverse Cardiac Remodeling After Myocardial Infarction in Mice

20. Metabolomic Analysis of Liver Tissues for Characterization of Hepatocellular Carcinoma

23. Corrigendum to “Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study” [Dig. Liver Dis. 49 (2017) 802–808]

24. Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib

25. Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection

26. Discriminant biomarkers of acute respiratory distress syndrome associated to H1N1 influenza identified by metabolomics HPLC-QTOF-MS/MS platform

27. Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study

28. Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery

30. Erratum: CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis

31. Multi-omic approaches for characterization of hepatocellular carcinoma

33. CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis

34. To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients

36. GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort

37. Ceramide Mediates Acute Oxygen Sensing in Vascular Tissues

38. Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes

Catalog

Books, media, physical & digital resources